Florida-based Earth Science Tech Inc. (ETST), a producer of hemp-derived CBD products sold nationally, recently announced it is taking several efforts to reach a wider customer base and expand sales in the United States and Latin America.
This could present investors with a potential growth stock opportunity, albeit a risky one, as this is still a penny stock.
Earth Science develops nutraceuticals, bioceuticals, and dietary supplements for the health, nutrition, cosmetic, and alternative medicine markets. Its CBD supplements are often bought as treatments for pain, inflammation, seizures, high blood pressure, memory loss, depression, weight management, nausea, and aging. They include vitamins, minerals, herbs, botanicals, personal care products, homeopathies, and functional foods—and come as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders, and whole herbs.
Earth Science offers its full spectrum hemp-derived CBD products through the internet and 200 retail shops, such as vitamin shops, chiropractors, natural food stores, and vaping/smoke shops in the UnUS. View its products at www.EarthScienceTech.com
In recent years, Earth Science Tech has maintained a low sales volume, with sales not yet breaking above $200k per year. As a result, its stock price has stayed below one dollar for most of the last three years, with a few brief exceptions. It closed today at $0.67.
However, with the passage of the US Farm Bill of 2018 in October, which federally legalized hemp and hemp-derived products such as its line of CBD products, there have been many predictions of significant new market growth. This has apparently spurred the company to grow its sales team and expand its full-spectrum cannabidiol (CBD) product distribution.
Recent predictions for the industry speculate it could grow to reach $16 billion in the US by 2025 (http://cnw.fm/94F1j).
Earth Science Tech’s initiatives include the following:
-ETST is growing its product distribution in the U.S. via recent agreements with CannaBiz and Dessert Sun Distribution (http://cnw.fm/a83oE). These companies will distribute ETST’s CBD products to pharmacies, chiropractors, dispensaries, athletic clubs and clinics throughout the US.
-ETST is launching a white label initiative to allow other CBD marketers to buy ETST High Grade Full Spectrum CBD line and rebrand it to their own brands.
-In January, ETST partnered with Forzagen, a dietary supplement provider, to distribute CBD products throughout Mexico and South America (http://cnw.fm/CsLv3). Forzagen’s distribution network includes large retailers like Sam’s Club and Petco, promising potential revenue gains for ETST. The deal gives Forzagen exclusivity for Latin American distribution.
It has four wholly-owned subsidiaries:
Earth Science Pharmaceutical Inc. (http://cnw.fm/vsF3P) creates low-cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and diseases. Hygee is the company’s first medical device, first launched in Vietnam. It provides women with a discreet home testing solution for chlamydia.
Cannabis Therapeutics Inc. (http://cnw.fm/ovt9W) develops cannabinoid-based pharmaceutical and nutraceutical products. Currently, the company is developing treatments for breast and ovarian cancers. This focus is part of a larger commitment by ETST to improve the health of women around the world.
KannaBidioiD Inc. (http://cnw.fm/JL5eq) develops recreational CBD products, such as infused vapes and e-liquids, as well as assisting with nicotine reduction therapy.
Earth Science Foundation Inc. (http://cnw.fm/v9T3Y) is working toward nonprofit status. Its purpose is to provide ETST with CBD products for people with cancer, epilepsy, autism, chronic pain and depression.
ETST is able to legally ship products to all 50 states. Additional information can be found at Earth Science Tech Inc. (OTCQB: ETST)
For more information, visit the company’s website at www.EarthScienceTech.com
Sources ETST press release